ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$64.82 USD
-1.21 (-1.83%)
Updated May 15, 2024 04:00 PM ET
After-Market: $64.66 -0.16 (-0.25%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth B Momentum A VGM
Brokerage Reports
ANI Pharmaceuticals, Inc. [ANIP]
Reports for Purchase
Showing records 81 - 88 ( 88 total )
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q13 Upside Should Continue into 2014; PT to $33
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Profitable Emerging Generic Company with Room to Grow
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S